Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript May 8, 2024 Y-mAbs Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Y-mAbs Therapeutics Inc. Earnings Conference Call for the First Quarter of 2024. […]
Amidst leadership changes and competitive pressures, Y-mAbs Therapeutics Inc reports robust U.S. sales growth and strategic global expansions.
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call